Copyright
©The Author(s) 2017.
World J Gastrointest Oncol. Aug 15, 2017; 9(8): 327-332
Published online Aug 15, 2017. doi: 10.4251/wjgo.v9.i8.327
Published online Aug 15, 2017. doi: 10.4251/wjgo.v9.i8.327
Table 3 Endoscopic score of risk for gastric cancer of the two groups
Group A (n = 109) | Group B (n = 83) | P value | |
Atrophy | 0.005 | ||
0 | 4 | 0 | |
1 | 6 | 0 | |
2 | 99 | 83 | |
Intestinal metaplasia | 0.1 | ||
0 | 60 | 35 | |
1 | 33 | 34 | |
2 | 16 | 14 | |
Fold swelling | 0.6 | ||
0 | 99 | 73 | |
1 | 10 | 10 | |
Nodular gastritis | 1.0 | ||
0 | 109 | 83 | |
1 | 0 | 0 | |
Diffuse redness | 0.5 | ||
0 | 4 | 0 | |
1 | 23 | 25 | |
2 | 82 | 58 | |
Total score, median [IQR] | 4 [4-5] | 4 [4-5] | 0.1 |
- Citation: Shibukawa N, Ouchi S, Wakamatsu S, Wakahara Y, Kaneko A. Gastric xanthoma is a predictive marker for metachronous and synchronous gastric cancer. World J Gastrointest Oncol 2017; 9(8): 327-332
- URL: https://www.wjgnet.com/1948-5204/full/v9/i8/327.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v9.i8.327